| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040752926 |
| P356 | DOI | 10.1007/S00115-008-2660-6 |
| P698 | PubMed publication ID | 19396418 |
| P50 | author | Hans-Jürgen Möller | Q1577771 |
| P2093 | author name string | R Rupprecht | |
| C Schüle | |||
| D Eser | |||
| J Damm | |||
| T C Baghai | |||
| P2860 | cites work | Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration | Q21092366 |
| The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: Evidence that they lie on a dimensional spectrum | Q22252423 | ||
| Antidepressants for neuropathic pain | Q24246575 | ||
| A rating scale for depression | Q24564540 | ||
| Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine | Q28240140 | ||
| Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group | Q28261686 | ||
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| A neurotrophic model for stress-related mood disorders | Q29616291 | ||
| Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration | Q29619529 | ||
| Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review | Q30997997 | ||
| Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms | Q31156853 | ||
| Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. | Q33385675 | ||
| Does almost everybody suffer from a bipolar disorder? | Q82621068 | ||
| Antidepressant treatment of the depressed patient with insomnia. | Q33710732 | ||
| Catatonia in depression: prevalence, clinical correlates, and validation of a scale | Q33735106 | ||
| Potential treatment for subthreshold and mild depression: a comparison of St. John's wort extracts and fluoxetine | Q33881140 | ||
| Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. | Q33897785 | ||
| Neuroimaging studies of mood disorders | Q33924331 | ||
| Catatonia in psychiatric classification: a home of its own. | Q33966841 | ||
| Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder | Q33977789 | ||
| Efficacy of milnacipran in patients with fibromyalgia. | Q33990528 | ||
| SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability | Q34066581 | ||
| Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders | Q34106678 | ||
| Hypericum perforatum--a review of clinical studies | Q34343887 | ||
| Antidepressants for bipolar depression: a systematic review of randomized, controlled trials | Q34344394 | ||
| When do antidepressants worsen the course of bipolar disorder? | Q34429760 | ||
| Efficacy and tolerability of Hypericum extract STW 3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial | Q34553518 | ||
| New antidepressants in the treatment of neuropathic pain. A review. | Q34618290 | ||
| Synaptic plasticity and mood disorders | Q34622373 | ||
| Somatic symptoms, depression, and antidepressant treatment | Q34631241 | ||
| Which antidepressants have demonstrated superior efficacy? A review of the evidence | Q34698836 | ||
| St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy | Q34749927 | ||
| Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways | Q34788161 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression | Q35024109 | ||
| Dual monoamine modulation for improved treatment of major depressive disorder | Q35051833 | ||
| St. John's Wort. An option for the primary care treatment of depressive patients? | Q35194844 | ||
| Effects of different antidepressant treatments on the core of depression. | Q35237015 | ||
| The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression | Q35557193 | ||
| Atypical antipsychotics for bipolar disorder | Q36096466 | ||
| Antidepressant treatment in the primary care office: outcomes for adjustment disorder versus major depression | Q36216509 | ||
| The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy | Q36251604 | ||
| Recurrent brief depression revisited | Q36272491 | ||
| Treatment of depression with atypical features: a meta-analytic approach | Q36328170 | ||
| Are all antidepressants really the same? The case of fluoxetine: a systematic review. | Q36539416 | ||
| Resurrecting melancholia | Q36728887 | ||
| The facets of melancholia. | Q36728895 | ||
| Atypical depression: current status and relevance to melancholia. | Q36728898 | ||
| Sleep and circadian rhythms in mood disorders | Q36728904 | ||
| Treatment response in melancholia | Q36728911 | ||
| Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. | Q37039104 | ||
| Electroconvulsive therapy and its different indications | Q37160214 | ||
| Contemporary management of depression | Q40650598 | ||
| Psychotic depression | Q40984818 | ||
| The Zurich Study--a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. IV. Recurrent and nonrecurrent brief depression | Q41484547 | ||
| A double-blind trial of bupropion versus desipramine for bipolar depression | Q42282008 | ||
| A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder | Q42680831 | ||
| Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders | Q44136927 | ||
| Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study | Q44141572 | ||
| Recurrent brief depressive episodes. Epidemiology, clinical aspects, diagnosis and therapy | Q44257793 | ||
| Facet theoretic analysis of the Hamilton-D scale | Q44581899 | ||
| Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders | Q44623818 | ||
| A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. | Q46326672 | ||
| Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. | Q46639899 | ||
| Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. | Q46665464 | ||
| A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia | Q46826909 | ||
| New insights into the pathogenesis and pathophysiology of depression | Q46932234 | ||
| Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression | Q46965381 | ||
| One-year follow-up after successful ECT: a naturalistic study in depressed inpatients | Q47241751 | ||
| An international study of the relation between somatic symptoms and depression | Q47697842 | ||
| Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis | Q48284345 | ||
| A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression | Q48732179 | ||
| Antidepressant effects of light in seasonal affective disorder | Q49049974 | ||
| The Ham D(6) is more homogenous and as sensitive as the Ham D(17). | Q51906169 | ||
| Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality. | Q51907241 | ||
| Perceived parental rearing of bipolar offspring. | Q51908299 | ||
| Clinical and demographic factors associated with DSM-IV melancholic depression. | Q51916469 | ||
| Do many patients with depression suffer from bipolar disorder? | Q51921094 | ||
| Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences. | Q51935449 | ||
| ECT in the treatment of the catatonic syndrome. | Q52031811 | ||
| The effects of phototherapy in the general population. | Q52058977 | ||
| Suicidal tendencies as a complication of light therapy for seasonal affective disorder: a report of three cases | Q57739406 | ||
| [Elements for the effective treatment of patients with depressive disorders at the primary care level] | Q58444392 | ||
| A proposed new approach to the clinical subclassification of depressive illness | Q68335758 | ||
| The Hamilton depression scale. Evaluation of objectivity using logistic models | Q70151155 | ||
| Are benzodiazepines antidepressants? | Q71345539 | ||
| Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression | Q71832243 | ||
| Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants | Q72078495 | ||
| Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression | Q72547745 | ||
| Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts | Q72626119 | ||
| Comparison of the diagnosis of melancholic and atypical features according to DSM-IV and somatic syndrome according to ICD-10 in patients suffering from major depression | Q73466896 | ||
| Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study | Q73825653 | ||
| A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life | Q74525461 | ||
| Is Catatonia a Primary Indication for ECT? | Q77901811 | ||
| Catatonia and DSM-IV | Q77902236 | ||
| [Problems of evidence-based medicine in psychopharmacotherapy: problems of evidence grading and of the evidence basis for complex clinical decision making] | Q80430032 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 515-6, 518, 520 passim | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Der Nervenarzt | Q15446312 |
| P1476 | title | [Core symptoms of depression. Effectiveness of antidepressant therapy] | |
| P478 | volume | 80 |
| Q85185566 | Efficiency of antidepressant therapy for patients with less severe depression |
| Q51498641 | Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. |
| Q84789427 | [Core symptoms of depression] |
Search more.